The WHO global influenza surveillance and response system (GISRS)A future perspective

被引:107
作者
Hay, Alan J. [1 ]
McCauley, John W. [1 ]
机构
[1] Francis Crick Inst, London, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
GISRS; global influenza surveillance and response system; influenza; surveillance; WHO; RECEPTOR-BINDING PROPERTIES; ACUTE RESPIRATORY SYNDROME; GENETIC-CHARACTERISTICS; RISK-ASSESSMENT; CLINICAL-TRIAL; A VIRUSES; VACCINE; HEMAGGLUTININ; A(H3N2); HUMANS;
D O I
10.1111/irv.12565
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In the centenary year of the devastating 1918-19 pandemic, it seems opportune to reflect on the success of the WHO Global Influenza Surveillance and Response System (GISRS) initiated 70years ago to provide early warning of changes in influenza viruses circulating in the global population to help mitigate the consequences of such a pandemic and maintain the efficacy of seasonal influenza vaccines. Three pandemics later and in the face of pandemic threats from highly pathogenic zoonotic infections by different influenza A subtypes, it continues to represent a model platform for global collaboration and timely sharing of viruses, reagents and information to forestall and respond to public health emergencies.
引用
收藏
页码:551 / 557
页数:7
相关论文
共 67 条
[1]   Improving the selection and development of influenza vaccine viruses Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015 [J].
Alan, Hampson ;
Ian, Barr ;
Nancy, Cox ;
Ruben, Donis O. ;
Siddhivinayak, Hirve ;
Daniel, Jernigan ;
Jacqueline, Katz ;
John, McCauley ;
Fernando, Motta ;
Takato, Odagiri ;
Tam, John S. ;
Anthony, Waddell ;
Richard, Webby ;
Thedi, Ziegler ;
Zhang Wenqing .
VACCINE, 2017, 35 (08) :1104-1109
[2]   Virus-specific T cells as correlate of (cross-)protective immunity against influenza [J].
Altenburg, Arwen F. ;
Rimmelzwaan, Guus F. ;
de Vries, Rory D. .
VACCINE, 2015, 33 (04) :500-506
[3]  
[Anonymous], 2016, INFECT CFDCA REPORTE
[4]  
[Anonymous], 2017, GERM 2017 BERL DECL
[5]   WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013 [J].
Barr, Ian G. ;
Russell, Colin ;
Besselaar, Terry G. ;
Cox, Nancy J. ;
Daniels, Rod S. ;
Donis, Ruben ;
Engelhardt, Othmar G. ;
Grohmann, Gary ;
Itamura, Shigeyuki ;
Kelso, Anne ;
McCauley, John ;
Odagiri, Takato ;
Schultz-Cherry, Stacey ;
Shu, Yuelong ;
Smith, Derek ;
Tashiro, Masato ;
Wang, Dayan ;
Webby, Richard ;
Xu, Xiyan ;
Ye, Zhiping ;
Zhang, Wenqing .
VACCINE, 2014, 32 (37) :4713-4725
[6]  
Bermingham A, 2012, EUROSURVEILLANCE, V17, P6
[7]   Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells [J].
Chizhmakov, IV ;
Geraghty, FM ;
Ogden, DC ;
Hayhurst, A ;
Antoniou, M ;
Hay, AJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1996, 494 (02) :329-336
[8]  
Convention on Biological Diversity, NAG PROT ACC BEN SHA
[9]   Pandemic Preparedness and the Influenza Risk Assessment Tool (IRAT) [J].
Cox, Nancy J. ;
Trock, Susan C. ;
Burke, Stephen A. .
INFLUENZA PATHOGENESIS AND CONTROL - VOL I, 2014, 385 :119-+
[10]   Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide [J].
Deyde, Varough M. ;
Xu, Xiyan ;
Bright, Rick A. ;
Shaw, Michael ;
Smith, Catherine B. ;
Zhang, Ye ;
Shu, Yuelong ;
Gubareva, Larisa V. ;
Cox, Nancy J. ;
Klimov, Alexander I. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (02) :249-257